NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: Role of the ventral tegmental area and central nucleus of the amygdala

Neuropsychopharmacology

Volumn 34, Issue 2, 2009, Pages 266-281

  Kenny, Paul J ^a   Chartoff, Elena ^b   Roberto, Marisa ^c   Carlezon Jr , William A ^b   Markou, Athina ^d  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central amygdala; Intravenous self administration; Nicotine; NMDA receptor; Reward; Ventral tegmental area

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REWARD; SELF STIMULATION; SMOKING HABIT; UPREGULATION; VENTRAL TEGMENTUM;

AMYGDALA; ANIMALS; BLOTTING, WESTERN; CATHETERIZATION; ELECTRODES, IMPLANTED; EXCITATORY POSTSYNAPTIC POTENTIALS; FEEDING BEHAVIOR; ISOQUINOLINES; MALE; NICOTINE; NUCLEUS ACCUMBENS; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REWARD; SELF ADMINISTRATION; VENTRAL TEGMENTAL AREA;

EID: 57849083126     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.58     Document Type: Article

References (84)

1. Barazangi N, Role LW (2001). Nicotine-induced enhancement of glutamatergic and gabaergic synaptic transmission in the mouse amygdala. J Neurophysiol 86: 463-474.
2. Barr RS, Pizzagalli DA, Culhane MA, Goff DC, Evins AE (2007). A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence. Biol Psychiatry in press.
3. Bauco P, Wise RA (1994). Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol Exp Ther 271: 294-301.
4. Ben-Shahar O, Keeley P, Cook M, Brake W, Joyce M, Nyffeler M et al (2007). Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to iv cocaine. Brain Res 1131: 220-228.
5. Brunzell DH, Russell DS, Picciotto MR (2003). In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57BL/6J mice. J Neurochem 84: 1431-1441.
6. Buisson B, Bertrand D (2002). Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol Sci 23: 130-136.
7. Carboni E, Bortone L, Giua C, Di Chiara G (2000). Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend 58: 93-102.
8. Carlezon Jr WA, Wise RA (1993). Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration. Psychopharmacology (Berl) 111: 402-408.
9. Caine SB, Lintz R, Koob GF (1993). Intravenous drug self-administration techniques in animals. In: Sahgal A (ed). Behavioural Neuroscience: A Practical Approach, vol 2. IRL Press: Oxford. pp 117-143.
10. Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon Jr WA (2006). Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci 26: 6450-6457.
11. Corrigall WA, Coen KM, Adamson KL (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653: 278-284.
12. Corrigall WA, Franklin KB, Coen KM, Clarke PB (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 107: 285-289.
13. Cull-Candy S, Brickley S, Farrant M (2001). NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11: 327-335.
14. Dani JA, Heinemann S (1996). Molecular and cellular aspects of nicotine abuse. Neuron 16: 905-908.
15. David V, Besson M, Changeux JP, Granon S, Cazala P (2006). Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50: 1030-1040.
16. Dingledine R, Borges K, Bowie D, Traynelis SF (1999). The glutamate receptor ion channels. Pharmacol Rev 51: 7-61.
17. Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, Gharib MA et al (2003). Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl) 169: 68-76.
18. Fischer BD, Dykstra LA (2006). Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 318: 1300-1306.
19. Fu Y, Matta SG, Gao W, Brower VG, Sharp BM (2000). Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J Pharmacol Exp Ther 294: 458-465.
20. Ghasemzadeh MB, Nelson LC, Lu XY, Kalivas PW (1999). Neuroadaptations in ionotropic and metabotropic glutamate receptor MRNA produced by cocaine treatment. J Neurochem 72: 157-165.
21. Goeders NE, Smith JE (1984). Parameters of intracranial self-administration of cocaine into the medial prefrontal cortex. NIDA Res Monogr 55: 132-137.
22. Grillner P, Svensson TH (2000). Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation. Synapse 38: 1-9.
23. Harrison AA, Gasparini F, Markou A (2002). Nicotine potentiation of brain stimulation reward reversed by DhbE and SCH 23390, but not by eticlopride, LY314582 or MPEP in rats. Psychopharmacology (Berl) 160: 56-66.
24. Hatton GI, Yang QZ (2002). Synaptic potentials mediated by alpha 7 nicotinic acetylcholine receptors in supraoptic nucleus. J Neurosci 22: 29-37.
25. Hemby SE, Tang W, Muly EC, Kuhar MJ, Howell L, Mash DC (2005). Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates. J Neurochem 95: 1785-1793.
26. Herberg LJ, Rose IC (1989). The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology (Berl) 99: 87-90.
27. Huston-Lyons D, Kornetsky C (1992). Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol Biochem Behav 41: 755-759.
28. Hwang YY, Li MD (2006). Proteins differentially expressed in response to nicotine in five rat brain regions: identification using a 2-DE/MS-based proteomics approach. Proteomics 6: 3138-3153.
29. Ikemoto S, Qin M, Liu ZH (2006). Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area. J Neurosci 26: 723-730.
30. Jackson A, Brown G, Stephens DN (1996). N-methyl-D- aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA) glutamate-receptor antagonists have different interactions with the discriminative stimuli of abused drugs. Psychopharmacology (Berl) 128: 320-327.
31. Jacobs EH, Smit AB, de Vries TJ, Schoffelmeer AN (2005). Long-term gene expression in the nucleus accumbens following heroin administration is subregion-specific and depends on the nature of drug administration. Addict Biol 10: 91-100.
32. Jones S, Bonci A (2005). Synaptic plasticity and drug addiction. Curr Opin Pharmacol 5: 20-25.
33. Kalivas PW, Volkow ND (2005). The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413.
34. Kenny PJ (2007). Brain reward systems and compulsive drug use. Trends Pharmacol Sci 28: 135-141.
35. Kenny PJ, Gasparini F, Markou A (2003). Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J Pharmacol Exp Ther 306: 1068-1076.
36. Kenny PJ, Markou A (2004). The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol Sci 25: 265-272.
37. Kenny PJ, Markou A (2006). Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31: 1203-1211.
38. Kimmel HL, Ginsburg BC, Howell LL (2005). Changes in extracellular dopamine during cocaine self-administration in squirrel monkeys. Synapse 56: 129-134.
39. Konu O, Kane JK, Barrett T, Vawter MP, Chang R, Ma JZ et al (2001). Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res 909: 194-203.
40. Koob GF, Le HT, Creese I (1987). The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79: 315-320.
41. Kornetsky C, Esposito RU (1979). Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38: 2473-2476.
42. Kosowski AR, Cebers G, Cebere A, Swanhagen AC, Liljequist S (2004). Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551. Psychopharmacology (Berl) 175: 114-123.
43. Lambe EK, Picciotto MR, Aghajanian GK (2003). Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28: 216-225.
44. Lau CG, Zukin RS (2007). NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8: 413-426.
45. Laviolette SR, Alexson TO, van der Kooy D (2002). Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. J Neurosci 22: 8653-8660.
46. Laviolette SR, van der Kooy D (2003). The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor. Psychopharmacology (Berl) 166: 306-313.
47. Lecca D, Cacciapaglia F, Valentini V, Acquas E, Di Chiara G (2007). Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology (Berl) 191: 653-667.
48. Liechti ME, Lhuillier L, Kaupmann K, Markou A (2007). Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J Neurosci 27: 9077-9085.
49. Lu L, Dempsey J, Shaham Y, Hope BT (2005). Differential long-term neuroadaptations of glutamate receptors in the basolateral and central amygdala after withdrawal from cocaine self-administration in rats. J Neurochem 94: 161-168.
50. Lu L, Grimm JW, Shaham Y, Hope BT (2003). Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem 85: 1604-1613.
51. Lu L, Uejima JL, Gray SM, Bossert JM, Shaham Y (2007). Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving. Biol Psychiatry 61: 591-598.
52. Mansvelder HD, McGehee DS (2000). Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27: 349-357.
53. Mark GP, Hajnal A, Kinney AE, Keys AS (1999). Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology (Berl) 143: 47-53.
54. Markou A, Koob GF (1992). Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51: 111-119.
55. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP et al (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436: 103-107.
56. McBride WJ, Murphy JM, Ikemoto S (1999). Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101: 129-152.
57. Mead AN, Stephens DN (2003). Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice. J Neurosci 23: 1041-1048.
58. Naqvi NH, Rudrauf D, Damasio H, Bechara A (2007). Damage to the insula disrupts addiction to cigarette smoking. Science 315: 531-534.
59. Ornstein PL, Arnold MB, Augenstein NK, Deeter JB, Leander JD, Lodge D et al (1993). Unusual stereochemical preferences of decahydroisoquinoline-3-carboxylic acid competitive NMDA antagonists. Bioorg Med Chem Lett 3: 2067-2072.
60. Ortiz J, Fitzgerald LW, Charlton M, Lane S, Trevisan L, Guitart X et al (1995). Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21: 289-298.
61. Pagliusi SR, Tessari M, DeVevey S, Chiamulera C, Pich EM (1996). The reinforcing properties of nicotine are associated with a specific patterning of c-fos expression in the rat brain. Eur J Neurosci 8: 2247-2256.
62. Paterson NE, Balfour DJ, Markou A (2008). Chronic bupropion partially attenuated the reinforcement-enhancing, but not the reinforcing, effects of self-administered nicotine and enhanced the motivational properties of a nicotine-associated conditioned stimulus in rats. Nicotine Tob Res in press.
63. Paxinos G, Watson CH (eds) (1986). The Rat Brain Atlas in Stereotaxic Coordinates. Academic Press: London.
64. Pellegrino LJ, Pellegrino AS, Cushman AJ (eds) (1979). A Stereotaxic Atlas of the Rat Brain. Plenum Press: New York.
65. Pich EM, Pagliusi SR, Tessari M, Talabot-Ayer D, Hooft van Huijsduijnen R, Chiamulera C (1997). Common neural substrates for the addictive properties of nicotine and cocaine. Science 275: 83-86.
66. Prince HK, Conn PJ, Blackstone CD, Huganir RL, Levey AI (1995). Down-regulation of AMPA receptor subunit GluR2 in amygdaloid kindling. J Neurochem 64: 462-465.
67. Randle JC, Guet T, Cordi A, Lepagnol JM (1992). Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution. Eur J Pharmacol 215: 237-244.
68. Rice ME, Cragg SJ (2004). Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7: 583-584.
69. Roberto M, Bajo M, Crawford E, Madamba SG, Siggins GR (2006). Chronic ethanol exposure and protracted abstinence alter NMDA receptors in central amygdala. Neuropsychopharmacology 31: 988-996.
70. Roberto M, Madamba SG, Stouffer DG, Parsons LH, Siggins GR (2004). Increased GABA release in the central amygdala of ethanol-dependent rats. J Neurosci 24: 10159-10166.
71. Schilstrom B, Fagerquist MV, Zhang X, Hertel P, Panagis G, Nomikos GG et al (2000). Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 38: 375-383.
72. Schilstrom B, Nomikos GG, Nisell M, Hertel P, Svensson TH (1998). N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82: 781-789.
73. Schoepp DD, Ornstein PL, Salhoff CR, Leander JD (1991). Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist. J Neural Transm Gen Sect 85: 131-143.
74. Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR (1999). Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371: 123-135.
75. Stephens DN, Brown G (1999). Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/ kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466. Alcohol Clin Exp Res 23: 1914-1920.
76. Sun D, Huang W, Hwang YY, Zhang Y, Zhang Q, Li MD (2007). Regulation by nicotine of Gpr51 and Ntrk2 expression in various rat brain regions. Neuropsychopharmacology 32: 110-116.
77. Sziraki I, Sershen H, Hashim A, Lajtha A (2002). Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem Res 27: 253-261.
78. Tang WX, Fasulo WH, Mash DC, Hemby SE (2003). Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem 85: 911-924.
79. Todtenkopf MS, Parsegian A, Naydenov A, Neve RL, Konradi C, Carlezon Jr WA (2006). Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell. J Neurosci 26: 11665-11669.
80. Turchan J, Maj M, Przewlocka B (2003). The effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic system. Drug Alcohol Depend 72: 193-196.
81. Valjent E, Pages C, Herve D, Girault JA, Caboche J (2004). Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19: 1826-1836.
82. Wang F, Chen H, Steketee JD, Sharp BM (2007). Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration. Neuropsychopharmacology 32: 103-109.
83. Wilson JM, Nobrega JN, Corrigall WA, Coen KM, Shannak K, Kish SJ (1994). Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine. Brain Res 668: 39-45.
84. Yokel RA, Wise RA (1975). Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187: 547-549.